Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures

MLA

C. Rieu, et al. “Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures.” PharmacoEconomics, vol. 30, no. 7, Jan. 2012, pp. 565–73. EBSCOhost, https://doi.org/10.2165/11588320-000000000-00000〉.

APA

C. Rieu, M. Angalakuditi, M. Bensadon, C. Le Pen, P Paubel, & Albane Degrassat-Théas. (2012). Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures. PharmacoEconomics, 30(7), 565–573. https://doi.org/10.2165/11588320-000000000-00000〉

Chicago

C. Rieu, M. Angalakuditi, M. Bensadon, C. Le Pen, P Paubel, and Albane Degrassat-Théas. 2012. “Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures.” PharmacoEconomics 30 (7): 565–73. doi:10.2165/11588320-000000000-00000〉.